Mendel and beyond 14/10/22 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is allelic heterogeneity?

A

This is when different mutations the same allele at the same locus produce the same disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is locus heterogeneity?

A

This is a mutation in a different gene (loci) produce the same disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does heterozygous mean?

A

Having two different alleles of a particular gene or genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does homozygous mean?

A

Having two identical alleles of a particular gene or genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is sickle cell anaemia and its symptoms?

A

Sickle cell is a disorder that affects haemoglobin. This causes RBC that are crescent shaped, inflexible and tend to stick to the vascular endothelium (the innermost lining of blood vessels).

This results in vascular obstruction that produces localized hypoxemia (lack of oxygen), painful sickling crises, and infarctions of various tissues, including bone, spleen, kidneys, brain, and lungs (an infarction is tissue death due to hypoxemia). Premature destruction of the sickled erythrocytes decreases the number of circulating erythrocytes and the haemoglobin level, producing anaemia. The spleen becomes
enlarged (splenomegaly), but infarctions eventually destroy this organ, producing some loss of immune function. This contributes to the recurrent and sometimes fatal bacterial infections (especially pneumonia) that are commonly seen in persons with sickle cell disease. About 10% of persons with sickle cell disease experiences a stroke before age 20 years. In North America, it is estimated that the life expectancy of persons with sickle cell disease are reduced by about 30 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How common is sickle cell?

A

Sickle cell disease affects millions of people worldwide. It is most common among people whose ancestors come from Africa; Mediterranean countries such as Greece, Turkey, and Italy; the Arabian Peninsula; India; and Spanish-speaking regions in South America, Central America, and parts of the Caribbean.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is sickle cell a loss or gain of function?

A

This is a loss of function disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the inheritance of sickle cell?

A

This is autosomal recessive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What genetics cause sickle cell?

A

Sickle cell disease is typically caused by a single missense mutation (GAG to GTG) in the HBB gene that results in a substitution of valine for glutamic acid at position 6 of the β-globin polypeptide chain. This particular mutation accounts for 60-70% of sickle cell in the US.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes sickle cell?

A

In normal RBCs there are two subunits of alpha globulin produced by HBA gene and two subunits of beta globulin produced by HBB gene. Each of these subunits attach an iron containing molecule called heme which can attach an oxygen molecule.

In sickle cell the mutation in the HBB gene results in an amino acid substitution of valine for glutamic acid which alters the structure of the beta globulin known as haemoglobin S (HbS). Some other mutations in HBB can result in HbC and HbE.

This causes the haemoglobin molecules to aggregate, causing erythrocytes to assume a characteristic sickle shape under conditions of low oxygen tension, inflexibility, insolubility and stickier. This reason for these issues is because the amino acids that are switched have very different properties. Valine is bigger, polar, hydrophilic, and negatively charged, whereas glutamic acid is smaller, aliphatic, hydrophobic, and neutrally charged. This change scores 121 on Grantham’s score which is moderately radical and means that the change is not highly conserved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What environmental factors can suddenly cause a sickle cell crisis?

A

Crisis can happen when there is a sudden change in temperature, very strenuous or excessive exercise, dehydration, infections, stress, high altitudes, alcohol, smoking, pregnancy, and other medical conditions such as diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is sickle cell beneficial?

A

It can protect against malaria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the other types of sickle cell?

A

Hb Hyde park
Hb Kempsey
Hb hammersmith
B-thalassemia
a-thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Hb Hyde park?

A

Hb Hyde Park is a rare type of hereditary autosomal dominant mutation of CAC>TAC on codon 92 of beta globin HBB gene resulting in the replacement of histidine by tyrosine amino acid. This variant Hb has a tendency to form methaemoglobin (metHb). The iron ion in metHb is oxidized to ferric (Fe3+) which is unable to carry oxygen and the patients manifest as cyanosis. he ferric iron (Fe3+) in metHb is unable to carry oxygen or carbon dioxide. The oxygen affinity increases for the remaining ferrous (Fe2+) heme groups, so they bind to oxygen strongly and thus not ready to release oxygen to tissues. Patients are usually presented with cyanosis and the severity of the symptoms are proportional to the metHb level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Hb Kempsey?

A

Hb Kempsey is a type of hereditary autosomal dominant mutation of the beta globulin HBB gene where there is a change of amino acid from aspartic acid to asparagine at point 99 on the gene. This causes the Hb to keep its high affinity structure so less oxygen is available to tissue.
This causes polycythaemia (high level of RBCs in blood) in heterozygotes and is lethal in people who are homozygotes for asparagine. This is a gain of function mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the difference between B-thalassemia and a-thalassemia?

A

Thalassemia can be divided into two major groups, α-thalassemia and β-thalassemia. Depending on the globin chain that is reduced in quantity and unable to participate in normal tetramer formation the excess globulin will form molecules consisting of four chains of itself. These are termed homotetramers, in contrast to the heterotetramers normally formed by α and β chains.

In α-thalassemia, the α-globin chains are deficient, so the β chains (or γ chains in the foetus) are found in excess. They form homotetramers that have a greatly reduced oxygen-binding capacity, producing
hypoxemia.

In β-thalassemia, the excess α chains form homotetramers that precipitate and damage the cell membranes of red blood cell precursors. This leads to premature erythrocyte destruction and
anaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How common is thalassemia?

A

Thalassemia was first described in populations living near the Mediterranean Sea, although it is also common in portions of Africa, the Mideast, India, and Southeast Asia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is B-thalassemia?

A

β-thalassemia minor - β-globin mutation in one copy of chromosome 11. A condition that involves little or no anaemia and does not ordinarily require clinical management.

β-intermedia and β-major - β-globin mutation where both copies of the chromosome carry a β-globin mutation. β-intermedia is less severe.

In intermedia and major β-Globin may be completely absent (β0-thalassemia), or it may be reduced to about 10% to 30% of the normal amount (β+-thalassemia). Typically, β0-thalassemia produces a more severe disease phenotype, but because disease features are caused by an excess of α-globin chains, patients with β0-thalassemia are less severely affected when they also have α-globin mutations that reduce the quantity of α-globin chains.

B-globulin is not produced until 2-6 months after birth, so symptoms don’t develop until then. Symptoms are anaemia which causes bone marrow expansion, which in turn produces skeletal changes, including a protuberant upper jaw and cheekbones and thinning of the long bones, splenomegaly, and infections are common.

Mutations are normally SNPs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a-thalassemia?

A

α-thalassemia is caused by deletions of the α-globin genes. The loss of one or two of these genes has no clinical effect. The loss or abnormality of three of the α genes produces moderately severe anaemia and splenomegaly. Loss of all four α genes produces hypoxemia in the foetus and hydrops fetalis (a condition in which there is a massive build-up of fluid). Severe hydrops fetalis often causes stillbirth or neonatal death.

Everyone has two copies of HBA1 and HBA2.

20
Q

What is treatment for those with sickle cell and thalassemia?

A

Blood transfusions and with chelating agents that remove excess iron introduced by the transfusions. Prophylactic administration of antibiotics and antipneumococcal vaccine help to prevent bacterial infections, and analgesics are administered for pain relief during sickling crises. Bone marrow transplantation, which provides donor stem cells that produce genetically normal erythrocytes. A lack of normal adult β-globin can be compensated for by reactivating the genes that encode foetal β-globin. Agents such as hydroxycarbamide and butyrate can reactivate these genes and are being investigated. Also, β-thalassemia is a strong candidate for gene therapy. (Jorde et al., 2015).

21
Q

What is alkaptonuria and its symptoms?

A

Alkaptonuria is an inherited condition that causes urine to turn black when exposed to air. Ochronosis, a build-up of dark pigment in connective tissues such as cartilage and skin, is also characteristic of the disorder. This blue-black pigmentation usually appears after age 30. People with alkaptonuria typically develop arthritis, particularly in the spine and large joints, beginning in early adulthood. Other features of this condition can include heart problems, kidney stones, and prostate stones.

22
Q

Is AKU a loss or gain of function?

A

This is a loss of function disorder.

23
Q

What inheritance is AKU?

A

This is an autosomal recessive disorder.

24
Q

How common is AKU?

A

This condition is rare, affecting 1 in 250,000 to 1 million people worldwide. Alkaptonuria is more common in certain areas of Slovakia (where it has an incidence of about 1 in 19,000 people) and in the Dominican Republic.

25
Q

What genetics cause AKU?

A

Mutations in the HGD gene cause alkaptonuria. Mutations G115fs* and V157fs* are caused by genomic deletions that are predicted to cause exon 6 and 8 skipping, respectively, thus leading to frameshift.

26
Q

What causes AKU?

A

The HGD gene provides instructions for making an enzyme called homogentisate oxidase. This enzyme helps break down the amino acids phenylalanine and tyrosine, which are important building blocks of proteins. Mutations in the HGD gene impair the enzyme’s role in this process, and as a result, a substance called homogentisic acid, which is produced as phenylalanine and tyrosine, accumulates in the body. Excess homogentisic acid and related compounds are deposited in connective tissues, which causes cartilage and skin to darken. Over time, a build-up of this substance in the joints leads to arthritis. Homogentisic acid is also excreted in urine, making the urine turn dark when exposed to air.

27
Q

What is phenylketonuria and its symptoms?

A

Phenylalanine is an amino acid that is obtained through the diet. It is found in all proteins and in some artificial sweeteners. If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems.

The symptoms of PKU vary from mild to severe. The most severe form of this disorder is known as classic PKU. Infants with classic PKU appear normal until they are a few months old. Without treatment, these children develop permanent intellectual disability. Seizures, delayed development, behavioural problems, and psychiatric disorders are also common. Untreated individuals may have a musty or mouse-like odour as a side effect of excess phenylalanine in the body. Children with classic PKU tend to have lighter skin and hair than unaffected family members and are also likely to have skin disorders such as eczema.

28
Q

Is PKU a loss or gain of function?

A

This is a loss of function mutation.

29
Q

What inheritance is PKU?

A

This condition is inherited in an autosomal recessive pattern.

30
Q

How common is PKU?

A

About 1 in 10,000 babies born in the UK has PKU. Most cases of PKU are detected shortly after birth by new-born screening, and treatment is started promptly. As a result, the severe signs and symptoms of classic PKU are rarely seen.

31
Q

What genetics cause PKU?

A

Mutations in the PAH gene cause phenylketonuria. This has allelic heterogeneity with a wide range of different mutations causing the same disease.

32
Q

What causes PKU?

A

Mutations in the PAH gene cause phenylketonuria. The PAH gene provides instructions for making an enzyme called phenylalanine hydroxylase. This enzyme converts phenylalanine to other important compounds in the body. If gene mutations reduce the activity of phenylalanine hydroxylase, phenylalanine from the diet is not processed effectively. As a result, this amino acid can build up to toxic levels in the blood and other tissues. Because nerve cells in the brain are particularly sensitive to phenylalanine levels, excessive amounts of this substance can cause brain damage.

33
Q

What treatments for PKU?

A

A reduced diet of little protein to avoid intake of phenylalanine to help restore normal blood levels. Sapropterin dihydrochloride, a form of
tetrahydrobiopterin (BH4) can help BH-4 responsive PKU patients. Phenylalanine is crucial for normal growth and develop so a fine line much be balanced to keep some phenylalanine in the body for normal development and processes but not too much as to cause problems.

34
Q

What is tyrosinase-negative oculocutaneous albinism and its symptoms?

A

Albinism is characterised as a condition affecting melanin production. Lack of pigment in hair, skin and irises, light sensitivity, vision issues, and increased risk of skin cancer.

There are 4 different types of albinism.
Oculocutaneous albinism type 1 is characterized by white hair, very pale skin, and light-coloured irises. (Gene TYR).
Type 2 is typically less severe than type 1; the skin is usually a creamy white colour and hair may be light yellow, blond, or light brown. (Gene OCA2).
Type 3 includes a form of albinism called rufous oculocutaneous albinism, which usually affects dark-skinned people. Affected individuals have reddish-brown skin, ginger or red hair, and hazel or brown irises. (Gene TYRP1).
Type 3 is often associated with milder vision abnormalities than the other forms of oculocutaneous albinism. (Gene SLC45A2).

35
Q

Is albinism a loss or gain of function?

A

It is a loss of function mutation.

36
Q

What inheritance is albinism?

A

This is an autosomal recessive pattern disorder.

37
Q

How common is albinism?

A

About 1 in 20,000 worldwide.

38
Q

What genetics are albinism?

A

Mutations in the TYR gene cause type 1, mutations in the OCA2 gene are responsible for type 2, TYRP1 mutations cause type 3, and changes in the SLC45A2 gene result in type 4.

39
Q

What causes albinism?

A

Mutations in the genes associated with oculocutaneous albinism are involved in producing a pigment called melanin, which is the substance that gives skin, hair, and eyes their colour. In the retina, melanin also plays a role in normal vision. Mutations in any of these genes disrupt the ability of cells to make melanin, which reduces pigmentation in the skin, hair, and eyes. A lack of melanin in the retina leads to the vision problems characteristic of oculocutaneous albinism.

40
Q

What is tyrosinemia type 1 and its symptoms?

A

Tyrosinemia is a genetic disorder characterized by disruptions in the multistep process that breaks down the amino acid tyrosine. If untreated, tyrosine and its by-products build up in tissues and organs, which can lead to serious health problems.

Tyrosinemia type I is the most severe form of this disorder, it is characterized by symptoms that begin in the first few months of life. Failure to gain weight and grow, this is due to poor food tolerance because high-protein foods lead to diarrhoea and vomiting. Yellowing of the skin and whites of the eyes (jaundice), a cabbage-like odour, and an increased tendency to bleed.

Tyrosinemia type I can lead to liver and kidney failure, rickets, and an increased risk of liver cancer (hepatocellular carcinoma). Some affected children have repeated neurologic crises that consist of changes in mental state, reduced sensation in the arms and legs (peripheral neuropathy), abdominal pain, and respiratory failure. These crises can last from 1 to 7 days. Untreated, children with tyrosinemia type I often do not survive past the age of 10.

41
Q

Is tyrosinemia a loss or gain of function?

A

This is a loss of function disorder.

42
Q

What inheritance is tyrosinemia?

A

This is an autosomal recessive disorder.

43
Q

How common is tyrosinemia?

A

About 1 in 100,000 worldwide, more common in Canada and Norway.

44
Q

What genetics causes tyrosinemia?

A

Mutations in the FAH gene cause this disorder. Mutations in the FAH, TAT, and HPD genes can cause tyrosinemia types I, II, and III,
respectively. A splice site mutation is common in Canadians and is thought to be caused by the founder effect. Missense and nonsense have also been found.

45
Q

What causes tyrosinemia?

A

In the liver, enzymes break down tyrosine in a five-step process, resulting in molecules that are either excreted by the kidneys or used to produce energy or make other substances in the body. The FAH gene provides instructions for the fumarylacetoacetate hydrolase enzyme, which is responsible for the final step of tyrosine breakdown. As a result, tyrosine, fumarylacetoacetate, and maleylacetoacetate, are thought to be mutagenic and toxic to the liver and its tyrosines by-products (succinylacetone) accumulate to toxic levels, which can cause damage and death to cells in the liver, kidneys, nervous system, and other organs.

46
Q

How is tyrosinemia treated?

A

A specialed diet is important as well where little protein is eaten to minimize intake of intake of
Phenylalanine and Tyrosine. NTBC or nitisinone drugs, an inhibitor of an enzyme upstream of FAH (4-hydroxyphenylpyruvate dioxygenase).
The use of NTBC, combined with a low-tyrosine diet, has produced marked improvement in children with HT1.

47
Q

What is the phenylalanine hydroxylation pathway associated with alkaptonuria, phenylketonuria, tyrosinase-negative oculocutaneous albinism, alkaptonuria, and tyrosinemia type 1?

A

Phenylalanine
|
(1) Phenylalanine hydroxylase
|
Tyrosine —–> Dopamine —– (2) Tyrosinase –>
| | (3) Tyrosine aminotransferase Melanin
|
4-hydroxyphenylpyruvate
|
(4) 4-hydroxyphenylpyruvate oxidase
|
Homogentisic acid
|
(5) Homogentisic acid oxidase
|
Maleylacetoacetate
|
(6) Maleylacetoacetate isomerase
|
Fumarylacetoacetate
|
(7) Fumarylacetoacetate hydrolase
|
Fumarate + Acetoacetate

(1) = PKU
(2) = Tyrosinase-negative oculocutaneous albinism
(5) = AKU
(7) = Tyrosinemia type 1